Seminar Series

2010-2011

07/08/10   David Favre, D.V.M, Ph.D., Senior Scientist, National Immune Monitoring Laboratory,
Genome Quebec/Universite de Montreal, Montreal, Canada “HIV and Th17 Depletion: Implication for
AIDS Pathogenesis and Vaccine Development”

10/14/10   William B. Messer, M.D., Ph.D., Postdoctoral Fellow, Department of Medicine, Division
of Infectious Diseases, UNC Hospitals, Chapel Hill, NC “Development and Characterization of a
Dengue Virus Serotype 3 Infectious Clone: Reverse Genetics, Antigenic Diversity and Beyond”

10/29/10   Amy Moran, Ph.D., Postdoctoral Fellow, Microbiology, Immunology & Cancer Biology
(MICaB) Ph.D. Graduate Program, University of Minnesota Center for Immunology, Minneapolis, MN
“The role of TCR signal strength in thymic development”

11/19/10   Scott G. Kitchen, Ph.D., Assistant Professor of Medicine, Director, UCLA DVAR
Mouse/Human Chimera Core, Division of Hematology/Oncology, The David Geffen School of Medicine at
UCLA, Los Angeles, CA “Genetic Vaccination: Engineering Antiviral T-Cell Immunity Through Stem
Cells”

01/21/11            Robert S. Fujinami, Ph.D., Professor of Pathology, University of Utah School of Medicine, Salt Lake City, Utah “Same Virus – Two Different Diseases”

02/08/11            Nevan Krogan, Ph.D., Associate Professor, Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA.  “Functional Insights from Protein-Protein and Genetic Interaction Maps”

02/11/11            W. Ian Lipkin, M.D.,  Director of the Center for Infection and Immunity, The Northeast Biodefense Center,  World Health Organization collaborating Centre on Diagnostics, Surveillance and Immunotherapeutics on Emerging Infectious and Zoonotic Diseases, Columbia University, New York, NY, “Microbe Hunting”

03/15/11        Tomer Hertz, Ph.D., Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA “Computational and Experimental Investigation of Host Pathogen Co-Evaluation in Influenza Infection”

04/07/11        James J. Kobie, Ph.D., Co-director of the Center for Biodefense of Immunocompromised Populations, University of Rochester, Rochester, New York “Understanding the B cell response to HIV: Implications for vaccine design”

04/28/11        Roland K. Strong, Ph.D., Member, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA “The Biophysics of Designing HIV vaccines: Understanding (and Eliciting) Neutralizing Antibodies”

06/17/11        Ben J. Burwitz, Ph.D., Research Associate, Department of Pathology and Laboratory Medicine, University of Wisconsin – Madison, Madison, WI “Mauritian Cynomolgus macaques: An MHC-simplified non-human primate model to understand correlates of protection against SIV”

07/15/11        Huma Qureshi, Ph.D., Postdoctoral Fellow, Infectious Disease Unit, California National Primate Research Center, Center of Comparative Medicine, University of California, Davis, Davis, CA “Penile transmission of SIV in Ad5 seropositive rhesus macaques immunized with replication defective MRKAd5SIV gag/pol/nef vaccine”

07/27/11        Guangwu Xu, M.D., Ph.D., Postdoctoral Fellow, Department of Molecular Microbiology and Immunology, Oregon Helath & Science University, Portland, OR “The development of CMV-based cancer vaccines”

Seminar Series

2011-2012

10/28/11        Angelle Desiree LaBeaud, M.D., Pediatric Infectious Diseases, Assistant Scientist, Associate Physician, Children’s Hospital Oakland Research Insititute, Center for Immunobiology and Vaccine Development, Oakland, CA “The Epidemilogy of Rift Valley Fever in Kenya”

11/03/11        Qiana Matthews, Ph.D., Division of Human Gene Therapy, University of Alabama, Birmingham “Creation of Novel Adenoviral Vectors for HIV Vaccine Development”

11/17/11        Lindsey Crawford, Department of Microbiology & Immunology, State University of New York, Upstate Medical University, Syracuse, New York  “Molecular Mechanisms of HTLV and KSHV Pathogenesis”

12/01/11        Stacia Phillips, Ph.D., Postdoctoral Fellow, The University of Minnesota – Minneapolis, MN  “Characterization of the HCMV tegument protein UL94 and its interaction with UL99”

12/01/11        Jay Levy, M.D., Professor, School of Medicine, Research Associate, Cancer Research Insititute, Head, Laboratory for Tumor and AIDS Virus Research, University of California, San Francisco, CA  “HIV/AIDS: 30 Years of Progress and Future Challenges”

12/08/11        Magdalena Angelova, Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana  “Human Cytomegalovirus dysregulates Wnt signaling by promoting b-catenin degradation”

01/23/12        Eric G Sandstrom, M.D., Ph.D., Professor, Venhalsan/Karolinska Institutet at Sodersjukhuset, Sweden, Honorary Professor of Medicine, Muhimbili University, College of Health Sciences, Dar es Salaam, Tanzania  “Broad and strong reactivity of a multiclade, multigene DNA prime/MVA boost HIV vaccine in phase I/II studies in Sweden and Tanzania”

01/24/12        Nina Bhardwaj, M.D., Ph.D., Professor of Medicine, Dermatology, Pathology, Director, NYU Cancer Institute’s Tumor Vaccine Program, NYU Langone Medical Center, New York, NY  “Modulation of anti-cancer immunity by dendritic cells”

04/02/12       Michael Oldstone, M.D., Professor, Department of Immunology & Microbal Science Head, Viral –Immunobiology  Laboratory, The Scripps Research Institute, LaJolla, CA “Pathogenesis of Arenaviral Disease: Depends on the Alpha-Dystroglycan”

07/19/12        Gershon Golomb, PhD., Professor of Pharmaceutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel Immunomodulation by Bisphosphonate Nanoparticles for Anti-inflammatory Therapy”

07/20/12        Inger K. Damon, M.D., Ph.D., FIDSA, CAPT USPHS, Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Division of High Consequence Pathogens and Pathology (DHCPP) Chief, Poxvirus and Rabies Branch, Atlanta, GeorgiaPoxviruses: Ancient, Yet Emerging viruses”

08/9/12          Todd Allen, PhD., Associate Professor of Medicine, Harvard Medical School, Associate Immunologist, Ragon Institute of MGH, MIT and Harvard, Charlestone, MA “Modeling the Efficacy of HIV-Specific Immune Responses in the Humanized BLT Mouse Model”

Seminar Series

2012-2013

10/18/12        Eric Bartee, PhD.,Postdoctoral Associate, Department of Molecular Genetics and Microbiology, University of Florida, Gainsville, FL “Oncolytic Virotherapy using Myxoma Virus”

10/25/12        Luka Cicin-Sain, MD., PhD,. Junior Professor (W1) Medical School Hannover, Department of Virology, Germany “Development and Optimization of Vaccine Concepts in the Mouse Model of CMV Infection”

 

 

 

 

 



 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player